Literature DB >> 26046336

Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program.

Barbara A Cornblatt1, Ricardo E Carrión1, Andrea Auther1, Danielle McLaughlin1, Ruth H Olsen1, Majnu John1, Christoph U Correll1.   

Abstract

OBJECTIVE: Early intervention and prevention of psychosis remain a major challenge. Prediction would be greatly advanced with improved ability to identify individuals at true risk, which, at present, is moderate at best. The authors tested a modified strategy to improve prediction by selecting a more homogeneous high-risk sample (attenuated positive symptom criteria only, age range of mid-teens to early 20s) than is currently standard, combined with a systematic selection of neurodevelopmental deficits.
METHOD: A sample of 101 treatment-seeking adolescents (mean age, 15.9 years) at clinical high risk for psychosis were followed clinically for up to 5 years (mean follow-up time, 3.0 years, SD=1.6). Adolescents were included only if they exhibited one or more attenuated positive symptoms at moderate to severe, but not psychotic, severity levels. Cox regression was used to derive a risk index.
RESULTS: The overall conversion rate to psychosis was 28.3%. The final predictor model, with a positive predictive validity of 81.8%, consisted of four variables: disorganized communication, suspiciousness, verbal memory deficits, and decline in social functioning during follow-up. Significant effects also suggest narrowing the risk age range to 15-22 years.
CONCLUSIONS: Clinical high risk criteria that emphasize disorganized communication and suspiciousness while also including compromised verbal memory and declining social functioning have the potential to improve predictive accuracy compared with attenuated positive symptoms used alone. On the resulting risk index (a weighted combination of the predictors), low scores were interpreted as signifying minimal risk, with little treatment necessary, high scores as suggesting aggressive intervention, and intermediate scores, although less informative, as supporting psychosocial treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26046336      PMCID: PMC4993209          DOI: 10.1176/appi.ajp.2015.13121686

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  46 in total

1.  The schizophrenia prodrome: treatment and high-risk perspectives.

Authors:  Barbara Cornblatt; Todd Lencz; Michael Obuchowski
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

2.  Generalized and specific neurocognitive deficits in prodromal schizophrenia.

Authors:  Todd Lencz; Christopher W Smith; Danielle McLaughlin; Andrea Auther; Emilie Nakayama; Lauren Hovey; Barbara A Cornblatt
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

3.  A bootstrap resampling procedure for model building: application to the Cox regression model.

Authors:  W Sauerbrei; M Schumacher
Journal:  Stat Med       Date:  1992-12       Impact factor: 2.373

4.  A stratified model for psychosis prediction in clinical practice.

Authors:  Chantal Michel; Stephan Ruhrmann; Benno G Schimmelmann; Joachim Klosterkötter; Frauke Schultze-Lutter
Journal:  Schizophr Bull       Date:  2014-03-07       Impact factor: 9.306

5.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

Review 6.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

7.  Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt
Journal:  Am J Psychiatry       Date:  2011-05-02       Impact factor: 18.112

8.  Premorbid IQ in schizophrenia: a meta-analytic review.

Authors:  Kristen A Woodberry; Anthony J Giuliano; Larry J Seidman
Journal:  Am J Psychiatry       Date:  2008-04-15       Impact factor: 18.112

9.  Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables.

Authors:  Dorien H Nieman; Stephan Ruhrmann; Sara Dragt; Francesca Soen; Mirjam J van Tricht; Johannes H T M Koelman; Lo J Bour; Eva Velthorst; Hiske E Becker; Mark Weiser; Don H Linszen; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2013-10-18       Impact factor: 9.306

10.  Premorbid functional development and conversion to psychosis in clinical high-risk youths.

Authors:  Sarah I Tarbox; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Robert Heinssen; Thomas H McGlashan; Scott W Woods
Journal:  Dev Psychopathol       Date:  2013-11
View more
  41 in total

Review 1.  Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.

Authors:  Jean Addington; Donald Addington; Sabina Abidi; Thomas Raedler; Gary Remington
Journal:  Can J Psychiatry       Date:  2017-07-21       Impact factor: 4.356

2.  Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis.

Authors:  Danielle McLaughlin; Ricardo E Carrión; Andrea M Auther; Doreen M Olvet; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Robert K Heinssen; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Terry E Goldberg; Philip D Harvey; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2016-04-22       Impact factor: 9.306

Review 3.  Language as a biomarker for psychosis: A natural language processing approach.

Authors:  Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff
Journal:  Schizophr Res       Date:  2020-06-01       Impact factor: 4.939

Review 4.  Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia.

Authors:  Junghee Lee; Michael F Green
Journal:  Trends Neurosci       Date:  2016-07-29       Impact factor: 13.837

5.  Prediction of psychosis across protocols and risk cohorts using automated language analysis.

Authors:  Cheryl M Corcoran; Facundo Carrillo; Diego Fernández-Slezak; Gillinder Bedi; Casimir Klim; Daniel C Javitt; Carrie E Bearden; Guillermo A Cecchi
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

6.  Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis.

Authors:  Daniel J Devoe; Megan S Farris; Parker Townes; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2018-05-11       Impact factor: 2.732

7.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

8.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25

Review 9.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

10.  Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Authors:  Randal G Ross; Sharon K Hunter; M Camille Hoffman; Lizbeth McCarthy; Betsey M Chambers; Amanda J Law; Sherry Leonard; Gary O Zerbe; Robert Freedman
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.